Oligonukleotid (Slovak Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oligonukleotid" in Slovak language version.

refsWebsite

Global rank Slovak rank

21doi.org

2^nd place

7^th place

20nih.gov

4^th place

21^st place

1aacrjournals.org

8,869^th place

6,526^th place

1osdd.net

low place

1sciencedirect.com

149^th place

118^th place

1worldcat.org

5^th place

1^st place

aacrjournals.org

mct.aacrjournals.org

Antisense oligonucleotides: basic concepts and mechanisms. Molecular Cancer Therapeutics, March 2002, s. 347–55. Dostupné online. PMID 12489851.

doi.org

dx.doi.org

Solid-Phase Synthesis of Phosphorothioate Oligonucleotides Using Sulfurization Byproducts for in Situ Capping. The Journal of Organic Chemistry, October 2018, s. 11577–11585. DOI: 10.1021/acs.joc.8b01553. PMID 30179468.
VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets. Database, 1 January 2014, s. bau103. DOI: 10.1093/database/bau103. PMID 25380780.
Antisense RNA gene therapy for studying and modulating biological processes. Cellular and Molecular Life Sciences, 1999, s. 334–58. DOI: 10.1007/s000180050296. PMID 10228554.
Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective. Toxicologic Pathology, January 2015, s. 78–89. DOI: 10.1177/0192623314551840. PMID 25385330.
Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics, July 2013, s. 486–97. DOI: 10.1007/s13311-013-0194-5. PMID 23686823.
Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?. Antisense & Nucleic Acid Drug Development, April 2000, s. 117–21. DOI: 10.1089/oli.1.2000.10.117. PMID 10805163.
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Research, April 1988, s. 3209–21. DOI: 10.1093/nar/16.8.3209. PMID 2836790.
Probing of Nucleic Acid Structures, Dynamics, and Interactions With Environment-Sensitive Fluorescent Labels. Frontiers in Chemistry, 2020, s. 112. DOI: 10.3389/fchem.2020.00112. PMID 32181238. (English)
Molecular Mechanisms of Antisense Oligonucleotides. Nucleic Acid Therapeutics, April 2017, s. 70–77. DOI: 10.1089/nat.2016.0656. PMID 28080221.
Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach. Developmental Biology, June 2000, s. 124–34. DOI: 10.1006/dbio.2000.9720. PMID 10885751.
Cross-protective effect of antisense oligonucleotide developed against the common 3' NCR of influenza A virus genome. Molecular Biotechnology, November 2013, s. 203–11. DOI: 10.1007/s12033-013-9670-8. PMID 23729285.
Nucleic acid-mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site. Molecular Biotechnology, May 2012, s. 27–36. DOI: 10.1007/s12033-011-9437-z. PMID 21744034.
ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy. G3 (Bethesda, Md.), 2017, s. 2931–2943. Dostupné online. DOI: 10.1534/g3.117.044024. PMID 28696921.
Antisense oligonucleotide therapy for neurodegenerative disease. The Journal of Clinical Investigation, August 2006, s. 2290–6. DOI: 10.1172/JCI25424. PMID 16878173.
Chromatographic and related studies of alkylamide phases.. Chromatographia, August 1994, s. 155–61. DOI: 10.1007/BF02274494.
Analysis of oligonucleotides by liquid chromatography with alkylamide stationary phase.. Open Chemistry, January 2015. DOI: 10.1515/chem-2015-0141.
Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides:: Retention prediction. Journal of Chromatography A, 2002-06-07, s. 167–182. Dostupné online. ISSN 0021-9673. DOI: 10.1016/S0021-9673(02)00306-0. PMID 12134814. (po anglicky)
5-Methoxysalicylic acid and spermine: a new matrix for the matrix-assisted laser desorption/ionization mass spectrometry analysis of oligonucleotides. Journal of the American Society for Mass Spectrometry, April 2001, s. 456–62. DOI: 10.1016/S1044-0305(01)00212-4. PMID 11322192.
An ESI-MS method for characterization of native and modified oligonucleotides used for RNA interference and other biological applications. Nature Protocols, March 2008, s. 351–6. DOI: 10.1038/nprot.2007.535. PMID 18323805.
Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Research, June 2002, s. 51e–51. DOI: 10.1093/nar/30.11.e51. PMID 12034852.
Multi-technique comparison of immobilized and hybridized oligonucleotide surface density on commercial amine-reactive microarray slides. Analytical Chemistry, April 2006, s. 2342–51. DOI: 10.1021/ac051812m. PMID 16579618.

nih.gov

ncbi.nlm.nih.gov

Solid-Phase Synthesis of Phosphorothioate Oligonucleotides Using Sulfurization Byproducts for in Situ Capping. The Journal of Organic Chemistry, October 2018, s. 11577–11585. DOI: 10.1021/acs.joc.8b01553. PMID 30179468.
VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets. Database, 1 January 2014, s. bau103. DOI: 10.1093/database/bau103. PMID 25380780.
Antisense RNA gene therapy for studying and modulating biological processes. Cellular and Molecular Life Sciences, 1999, s. 334–58. DOI: 10.1007/s000180050296. PMID 10228554.
Antisense oligonucleotides: basic concepts and mechanisms. Molecular Cancer Therapeutics, March 2002, s. 347–55. Dostupné online. PMID 12489851.
Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective. Toxicologic Pathology, January 2015, s. 78–89. DOI: 10.1177/0192623314551840. PMID 25385330.
Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics, July 2013, s. 486–97. DOI: 10.1007/s13311-013-0194-5. PMID 23686823.
Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?. Antisense & Nucleic Acid Drug Development, April 2000, s. 117–21. DOI: 10.1089/oli.1.2000.10.117. PMID 10805163.
Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Research, April 1988, s. 3209–21. DOI: 10.1093/nar/16.8.3209. PMID 2836790.
Probing of Nucleic Acid Structures, Dynamics, and Interactions With Environment-Sensitive Fluorescent Labels. Frontiers in Chemistry, 2020, s. 112. DOI: 10.3389/fchem.2020.00112. PMID 32181238. (English)
Molecular Mechanisms of Antisense Oligonucleotides. Nucleic Acid Therapeutics, April 2017, s. 70–77. DOI: 10.1089/nat.2016.0656. PMID 28080221.
Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach. Developmental Biology, June 2000, s. 124–34. DOI: 10.1006/dbio.2000.9720. PMID 10885751.
Cross-protective effect of antisense oligonucleotide developed against the common 3' NCR of influenza A virus genome. Molecular Biotechnology, November 2013, s. 203–11. DOI: 10.1007/s12033-013-9670-8. PMID 23729285.
Nucleic acid-mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site. Molecular Biotechnology, May 2012, s. 27–36. DOI: 10.1007/s12033-011-9437-z. PMID 21744034.
ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy. G3 (Bethesda, Md.), 2017, s. 2931–2943. Dostupné online. DOI: 10.1534/g3.117.044024. PMID 28696921.
Antisense oligonucleotide therapy for neurodegenerative disease. The Journal of Clinical Investigation, August 2006, s. 2290–6. DOI: 10.1172/JCI25424. PMID 16878173.
Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides:: Retention prediction. Journal of Chromatography A, 2002-06-07, s. 167–182. Dostupné online. ISSN 0021-9673. DOI: 10.1016/S0021-9673(02)00306-0. PMID 12134814. (po anglicky)
5-Methoxysalicylic acid and spermine: a new matrix for the matrix-assisted laser desorption/ionization mass spectrometry analysis of oligonucleotides. Journal of the American Society for Mass Spectrometry, April 2001, s. 456–62. DOI: 10.1016/S1044-0305(01)00212-4. PMID 11322192.
An ESI-MS method for characterization of native and modified oligonucleotides used for RNA interference and other biological applications. Nature Protocols, March 2008, s. 351–6. DOI: 10.1038/nprot.2007.535. PMID 18323805.
Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Research, June 2002, s. 51e–51. DOI: 10.1093/nar/30.11.e51. PMID 12034852.
Multi-technique comparison of immobilized and hybridized oligonucleotide surface density on commercial amine-reactive microarray slides. Analytical Chemistry, April 2006, s. 2342–51. DOI: 10.1021/ac051812m. PMID 16579618.

osdd.net

crdd.osdd.net

ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy. G3 (Bethesda, Md.), 2017, s. 2931–2943. Dostupné online. DOI: 10.1534/g3.117.044024. PMID 28696921.

sciencedirect.com

Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides:: Retention prediction. Journal of Chromatography A, 2002-06-07, s. 167–182. Dostupné online. ISSN 0021-9673. DOI: 10.1016/S0021-9673(02)00306-0. PMID 12134814. (po anglicky)

worldcat.org

Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides:: Retention prediction. Journal of Chromatography A, 2002-06-07, s. 167–182. Dostupné online. ISSN 0021-9673. DOI: 10.1016/S0021-9673(02)00306-0. PMID 12134814. (po anglicky)